The China Bank & Insurance Directory 2025 is the definitive resource for professionals navigating the Chinese financial sector. Covering hundreds of leading banks, insurers, investment firms, and leasing companies, the directory offers verified contact information, executive names, HQ details, company descriptions, subsidiaries, and more. Categories include commercial banks, foreign banks, reinsurance firms, securities companies, and policy insurers. Ideal for market researchers, financial service providers, and global business developers, this edition offers unmatched insights into China's complex financial ecosystem. The China Bank & Insurance Directory 2025 is the definitive resource for professionals navigating the Chinese financial sector. Covering hundreds of leading …

Gold price forecast turns bullish as traders flock to safe-haven assets on rising U.S. recession fears and dovish Fed policy signals. XAU/USD gains traction.

RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--European Commission (EC) Approves Merck's CAPVAXIVE® for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults.

• Event promotes diversity, equity, and inclusion in Brazil's mining sector • Company President to serve as event patron and moderator MANAUS, Brazil, March 26, 2025 (GLOBE NEWSWIRE) -- Brazil Potash Corp. ("Brazil Potash" or the "Company") (NYSE-American: GRO), a developer and builder of Brazil's largest potash fertilizer project, announced today that its wholly-owned subsidiary, Potássio do Brasil Ltda., will participate in "Diversibram 2025 - Mining Without Labels," an event organized by the Brazilian Mining Institute (IBRAM).

THE WOODLANDS, Texas , March 26, 2025 /PRNewswire/ -- Target Hospitality Corp. ("Target Hospitality", "Target" or the "Company") (NASDAQ: TH), one of North America's largest providers of vertically-integrated modular accommodations and value-added hospitality services, today reported results for the fourth quarter and year ended December 31, 2024. Financial and Operational Highlights Revenue of $386.3 million for the year ended December 31, 2024.

NEW YORK , March 26, 2025 /PRNewswire/ -- Foot Locker, Inc. (NYSE: FL) today announced that Franklin R. Bracken, currently Executive Vice President and Chief Commercial Officer, has been named to the role of President, effective immediately.

Many artificial intelligence (AI) stocks have sold off recently, presenting compelling buying opportunities for patient investors. But folks with a sizable amount of their portfolio in names like Nvidia (NVDA -0.66%) may be looking for other ideas.

Is artificial intelligence a bubble? That's the trillion-dollar question.

Apple's iPhone 16 series will be available in Indonesia from April 11, it said on Wednesday, after Jakarta lifted a ban on its sale following the company's more than $300 million investment plan.

AIRS, EGBN and FFWM have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2025.

The future is always in flux. No one saw the COVID-19 pandemic coming.

AVGO, COMM and DAN made it to the Zacks Rank #1 (Strong Buy) growth stocks list on March 26, 2025.

SO and EPRI team up to accelerate emerging energy technologies, ensuring a future of affordable, reliable and resilient power solutions.

CHESAPEAKE, Va.--(BUSINESS WIRE)--Dollar Tree, Inc. (NASDAQ: DLTR) today reported financial results for its fourth quarter ended February 1, 2025. “In the fourth quarter, our team was focused on successfully closing out the year, bringing the strategic review to a favorable conclusion, and setting Dollar Tree on a path to realize its full potential to create long-term value for our associates, customers, and shareholders,” said Mike Creedon, Chief Executive Officer. “We finished 2024 on a high.

SINGAPORE, SG / ACCESS Newswire / March 26, 2025 / Ryde Group Ltd (NYSE American:RYDE) ("Ryde'' or the "Company"), a technology company with a leading platform for mobility and quick commerce in Singapore, is marking Eid al-Fitr (also known as Hari Raya Aidilfitri in Southeast Asia)with a Double Cashback initiative for its loyal subscribers. From 17th March to 31st March, Ryde+ subscribers will receive an additional 3% cashback on all rides paid with RydeCoins, doubling the usual rewards.

Spot Debuts Alongside Latest Culinary Innovation with Signature Pizza Hut Flavors Designed to Dip and Dunk Just in Time for March Madness® PLANO, Texas , March 26, 2025 /PRNewswire/ -- Some people bring the party. Others bring the pizza.

VANCOUVER, British Columbia, March 26, 2025 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences:

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a leading immunotherapy company, invites current and prospective investors to its Investor Day program to be held on Tuesday, April 15, 2025, at 10:00 am PDT. The program will include an in-depth update on the company's business operations and recent R&D advancements. Key timelines for catalysts of product candidates will be presented, along with a discussion of ongoing clinical trials. “ImmunityBio commenced 2025 with.

4 IDEAYA/GSK presentations of IDE275 (GSK959) and 4 additional presentations across IDE397/MAT2A, IDE161/PARG, PRMT5, and KAT6/7 programs at AACR 2025 IDE275 (GSK959) has demonstrated a potential best-in-class preclinical profile in the MSI-H setting, with a unique binding mode from previously reported WRN inhibitors Phase 1 dose escalation trial ongoing in MSI-H solid tumors with GSK MSI-H prevalence has been reported at approximately 31%, 20%, and 19% in endometrial, colorectal, and gastric cancers, respectively SOUTH SAN FRANCISCO, Calif. , March 26, 2025 /PRNewswire/ -- IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a leading precision medicine oncology company, today announced the publication of abstracts …

Highlights for FY25 Q4 As expected, revenues of $2,097.6 million, a decrease of 19.7% compared to last year, resulting from continued softer demand and the Company's objective to reduce network inventory; Net loss of $44.5 million, a decrease of 114.7% compared to last year; Normalized EBITDA [1] of $239.8 million, a decrease of 44.6% compared to last year; Normalized diluted earnings per share [1] [2] of $0.98 in line with expectations, a decrease of $1.80 per share, and diluted earnings per share of $(0.60), a decrease of $4.55 per share, compared to last year; North American retail sales decreased by …